Form 4: ANI Pharmaceuticals Executive Withholds Shares for Tax Purposes
Insider Transaction Report
Meredith Cook, SR. VP, General Counsel & Secretary of ANI Pharmaceuticals Inc., withheld 2,071 shares of common stock valued at $66.3 per share for tax purposes related to restricted stock vesting.
Summary
- Meredith Cook, SR. VP, General Counsel & Secretary of ANI Pharmaceuticals Inc. (ANIP), reported a transaction on July 18, 2025.
- The transaction involved the disposition of 2,071 shares of common stock at a price of $66.3 per share.
- These shares were withheld for tax purposes, exempt under Rule 16(b)-3, in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported.
- Following this transaction, Meredith Cook beneficially owns 76,874 shares of ANI Pharmaceuticals Inc. common stock directly.
Sentiment
Score: 5
Explanation: The transaction is a routine administrative event (shares withheld for tax purposes) and does not indicate any significant positive or negative sentiment regarding the company's performance or outlook.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine administrative transaction related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 07/18/2025 | Date of transaction where shares were withheld for tax purposes. |
| 07/21/2025 | Date the Form 4 was signed by Meredith W. Cook. |
Keywords
ANI Pharmaceuticals, ANIP, Form 4, Insider Transaction, Stock Vesting, Tax Withholding, Meredith Cook, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.